Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with pediatric allogeneic ...

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company") today released a letter to shareholders from the Chairman of the Company's Board ...

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with ...

CytoMed has generated the critical cell banks for the iPSC-derived hybrid of gamma delta T and Natural Killer cell technology and is currently undergoing process development into a potentially very ...

EQS-News: Vita 34 AG / Key word (s): Legal Matter/Miscellaneous Vita 34 AG strengthens its international brand presence by change of name to FamiCord AG 06.02.2025 / 07:30 CET/CEST The issuer is ...

I gave birth to my first child and opted not to cut the cord-and, subsequently, the attached placenta-and allow it to fall away naturally. Cord non-severance is otherwise referred to as a lotus birth, ...

Cord blood banking involves collecting blood left in your newborn's umbilical cord and placenta and storing it for future ...

The global cell separation market size was valued at USD 9.74 billion in 2024 and is projected to reach from USD 10.69 ...